Business digest
US-headquartered gene therapy company Asklepios BioPharmaceutical has acquired Paris-based gene therapy company BrainVectis, a spin out from the French National Institute for Health and Medical Research.
US-headquartered gene therapy company Asklepios BioPharmaceutical has acquired Paris-based gene therapy company BrainVectis, a spin out from the French National Institute for Health and Medical Research.